Genprex Inc (GNPX)

Jul 22, 2025

Genprex Inc. Stock Analysis and ForecastRapid growth trajectories - jammulinksnews.com

Jul 22, 2025

Jul 22, 2025

What analysts say about Genprex Inc. stockSuperior stock growth - jammulinksnews.com

Jul 22, 2025

Jul 22, 2025

Is Genprex Inc. a good long term investmentGame-changing returns - jammulinksnews.com

Jul 22, 2025

Jul 20, 2025

What drives Genprex Inc. stock priceRemarkable growth - jammulinksnews.com

Jul 20, 2025

Jul 18, 2025

How Genprex Inc. stock performs during market volatilityMulti Bagger Alerts - Newser

Jul 18, 2025

Jul 18, 2025

Genprex (NASDAQ:GNPX) Stock Price Down 3.2% – Should You Sell? - Defense World

Jul 18, 2025

Jul 17, 2025

What makes Genprex Inc. stock price move sharplyFree Investment Group - beatles.ru

Jul 17, 2025

Jul 16, 2025

how genprex inc. stock performs during market volatilityFree Access to Community with 300% Return - Newser

Jul 16, 2025

Jul 15, 2025

Why Genprex Inc. stock attracts strong analyst attentionFree Access to Investment Community - Newser

Jul 15, 2025

Jun 24, 2025

Genprex Announces Positive Preclinical Results for GPX-002 - TipRanks

Jun 24, 2025

Jun 23, 2025

Genprex (GNPX) Unveils Promising Data for Diabetes Gene Therapy | GNPX Stock News - GuruFocus

Jun 23, 2025

Jun 23, 2025

Genprex Announces Positive Data for Diabetes Therapy - TipRanks

Jun 23, 2025

Jun 12, 2025

Genprex's Strategic Share Sale: Balancing Dilution Risks with Clinical Milestones - AInvest

Jun 12, 2025

Jun 11, 2025

Genprex Enters $12.5M Stock Purchase Agreement - TipRanks

Jun 11, 2025

Jun 11, 2025

Genprex (GNPX) Announces Plan to Sell 15 Million Shares | GNPX Stock News - GuruFocus

Jun 11, 2025

Jun 11, 2025

Genprex Files for Resale of 15 Million Shares - MarketScreener

Jun 11, 2025

Jun 11, 2025

Genprex Files to Sell 15 Million Shares, Boosting Financial Strategy - AInvest

Jun 11, 2025

Jun 10, 2025

genprex regains nasdaq compliance but faces bid price challenge By Investing.com - Investing.com Nigeria

Jun 10, 2025

Jun 09, 2025

genprex regains nasdaq compliance but faces bid price challenge - Investing.com

Jun 09, 2025

Jun 05, 2025

Genprex Collaborators Present Positive Preclinical Data on Diabetes Gene Therapy at the ASGCT 28th Annual Meeting - mx.advfn.com

Jun 05, 2025

Jun 05, 2025

Genprex (NASDAQ:GNPX) Shares Down 2.8% – Should You Sell? - Defense World

Jun 05, 2025

Jun 03, 2025

Genprex to Participate at BIO 2025 International Convention - BioSpace

Jun 03, 2025

Jun 03, 2025

Genprex to Participate at BIO 2025 International Convention | GN - GuruFocus

Jun 03, 2025

Jun 03, 2025

Genprex to Participate at BIO 2025 International Convention | GNPX Stock News - GuruFocus

Jun 03, 2025

Jun 03, 2025

Genprex Opens Partnership Discussions for Cancer and Diabetes Gene Therapies at BIO 2025 - Stock Titan

Jun 03, 2025

May 29, 2025

Genprex to Present Trial Design of Acclaim-3 Clinical Trial Evaluating Reqorsa® Gene Therapy in Small Cell Lung Cancer at 2025 ASCO Annual Meeting | GNPX Stock News - GuruFocus

May 29, 2025

May 29, 2025

Genprex to Present Trial Design of Acclaim-3 Clinical Trial Evaluating Reqorsa® Gene Therapy in Small Cell Lung Cancer at 2025 ASCO Annual Meeting - Nasdaq

May 29, 2025

May 28, 2025

Genprex Collaborators Present Positive Preclinical Data on Diabetes Gene Therapy at the ASGCT 28th Annual Meeting | GNPX Stock News - GuruFocus

May 28, 2025

May 28, 2025

Genprex (GNPX) Reports Promising Preclinical Data for Diabetes Gene Therapy | GNPX Stock News - GuruFocus

May 28, 2025